Developing small circular mRNA vaccines for improved immunization
Official title: Small Circular mRNA Vaccines
Funded at University of Michigan at Ann Arbor · NIH-11059920 · Data updated 2026-11-12
This study is testing new small circular mRNA vaccines to see if they can provide better protection against diseases with fewer doses and side effects, making immunizations safer and more effective for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | December 16, 2023 |
| Project end | January 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $513,077 |
| NIH project number | 5R01AI168684-04 |
| Project ID | NIH-11059920 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals seeking vaccination against infectious diseases or cancers who may benefit from improved vaccine technology.
✕Less likely to help
Patients who are not seeking vaccination or those with contraindications to mRNA vaccines may not receive benefit from this research.
What this research studies
This research focuses on creating small circular mRNA vaccines that aim to enhance the effectiveness and safety of immunizations. By utilizing advanced drug delivery systems, the study seeks to overcome the limitations of traditional vaccines, such as poor stability and weak immune responses. The approach involves synthesizing small circRNA, which is designed to be more biostable and efficiently delivered, potentially leading to better protection against diseases. Patients may benefit from more effective vaccines that require fewer doses and have fewer side effects.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer vaccines for a variety of diseases.
How similar studies have gone: Other research has shown promise in the use of mRNA vaccines, indicating that this approach could lead to significant advancements in vaccine technology.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Zhu, Guizhi — University of Michigan at Ann Arbor
- Study coordinator: Zhu, Guizhi
Related research
Other NIH-funded projects on the same topics.
-
Expanding genetic testing for cancer risk in patients and families
This study is working to make it easier for cancer patients in Michigan to get genetic testing for cancer risk by improving how doctors gather family history and assess genetic risks, so that more people can receive the important evaluations they need.
-
HEARTS hypertension and diabetes care in Guatemala
This grant tests how well the HEARTS primary care model works in Guatemala to improve blood pressure and blood sugar control for patients.
-
Why the retina can sometimes heal itself and how we might help it heal
This NIH grant explores how inflammation and neural cells interact in the zebrafish retina to understand retinal neuron death and regeneration, with potential implications for human vision.
-
Integrated Heart Health: A HEARTS-based approach to hypertension and diabetes in Guatemala
A study tests a team-based, stepwise care model to improve blood pressure and blood sugar control for people with both hypertension and diabetes in Guatemala.
-
Understanding how work exposures and genes influence ALS risk
A study is building a long-term group of people at higher risk for ALS to see how their jobs, exposures at work, and genes together affect if and when the disease might develop.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.